Sabra Health Care REIT, Inc.
SBRA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $190,037 | $189,150 | $183,543 | $182,346 |
| % Growth | 0.5% | 3.1% | 0.7% | – |
| Cost of Goods Sold | $69,654 | $61,102 | $59,933 | $59,838 |
| Gross Profit | $120,383 | $128,048 | $123,610 | $122,508 |
| % Margin | 63.3% | 67.7% | 67.3% | 67.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $12,560 | $12,514 | $12,728 | $13,032 |
| SG&A Expenses | $12,560 | $12,514 | $12,728 | $13,032 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $48,271 | $43,586 | $43,494 | $42,183 |
| Operating Expenses | $60,831 | $56,100 | $56,222 | $55,215 |
| Operating Income | $59,552 | $71,948 | $67,388 | $67,293 |
| % Margin | 31.3% | 38% | 36.7% | 36.9% |
| Other Income/Exp. Net | -$36,599 | -$5,909 | -$26,671 | -$20,218 |
| Pre-Tax Income | $22,953 | $66,039 | $40,717 | $47,075 |
| Tax Expense | $436 | $497 | $413 | $380 |
| Net Income | $22,538 | $65,542 | $40,304 | $46,695 |
| % Margin | 11.9% | 34.7% | 22% | 25.6% |
| EPS | 0.094 | 0.28 | 0.17 | 0.2 |
| % Growth | -66.4% | 64.7% | -15% | – |
| EPS Diluted | 0.093 | 0.27 | 0.17 | 0.19 |
| Weighted Avg Shares Out | 239,896 | 237,976 | 237,891 | 236,598 |
| Weighted Avg Shares Out Dil | 243,558 | 240,930 | 240,296 | 239,640 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $27,548 | $27,100 | $28,083 |
| Depreciation & Amortization | $48,511 | $43,586 | $43,494 | $42,308 |
| EBITDA | $100,365 | $137,173 | $111,311 | $125,194 |
| % Margin | 52.8% | 72.5% | 60.6% | 68.7% |